Patents Assigned to Dey, L.P.
-
Patent number: 8084461Abstract: The present invention relates to a dual bronchodilator inhalation solution, system, kit and method for relieving bronchospasm in patients suffering from chronic obstructive pulmonary disease (COPD). In one alternative embodiment, the solution of the present invention is a prepackaged, sterile, premixed, premeasured single unit dose of albuterol and ipratropium bromide for patients suffering from COPD. The present solution may be free of antimicrobial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 2.50 mg albuterol and about 0.50 mg ipratropium bromide in a 0.5 ml volume.Type: GrantFiled: January 18, 2005Date of Patent: December 27, 2011Assignee: Dey, L.P.Inventors: Imtiaz Chaudry, Partha Banerjee
-
Patent number: 7811606Abstract: Nasal pharmaceutical formulations comprising a drug substance having a specific particle size distribution profile are disclosed herein. Such profile provides increased bioavailability, increased efficacy or prolonged therapeutic effect of the drug substance when administered intranasally. The formulations of the present invention may comprise one or more corticosteroids having a specific particle size distribution profile. In a preferred embodiment, the corticosteroid is beclomethasone or a pharmaceutically acceptable derivative thereof for the treatment of one or more symptoms of rhinitis. Preferably, the drug substance is beclomethasone dipropionate. The formulations herein may be provided as an aqueous suspension suitable for inhalation via the intranasal route.Type: GrantFiled: April 16, 2003Date of Patent: October 12, 2010Assignee: Dey, L.P.Inventor: Imtiaz Chaudry
-
Patent number: 7348362Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.Type: GrantFiled: July 9, 2004Date of Patent: March 25, 2008Assignee: Dey, L.P.Inventors: Partha S. Banerjee, Imtiaz A. Chaudry, Stephen Pham
-
Patent number: 6814953Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.Type: GrantFiled: May 3, 2002Date of Patent: November 9, 2004Assignee: Dey L.P.Inventors: Partha S. Banerjee, Stephen Pham, Samuel O. Akapo, Imtiaz A. Chaudry
-
Publication number: 20040109826Abstract: Stabilized albuterol compositions are provided. The compositions are aqueous inhalation compositions containing albuterol; a buffer, such as citric acid; and a metal chelator, such as EDTA.Type: ApplicationFiled: February 4, 2003Publication date: June 10, 2004Applicant: Dey, L.P.Inventors: Ramana Malladi, Partha S. Banerjee, Satyajit V. Erram
-
Patent number: 6702997Abstract: The present invention relates to an albuterol inhalation solution, system, kit and method for relieving bronchospasm in children suffering from asthma. In one alternative embodiment, the solution of the present invention is a sterile, premixed, premeasured single unit dose of albuterol for asthmatic patients 2 to 12 years of age. The present solution may be free of anti-microbial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 0.63 mg or about 1.25 mg albuterol.Type: GrantFiled: December 28, 2001Date of Patent: March 9, 2004Assignee: Dey, L.P.Inventors: Imtiaz Chaudry, Partha Banerjee
-
Publication number: 20040023935Abstract: Bronchodilating concentrates and diluted compositions, methods of use thereof, and processes for making the concentrates and diluted compositions, are provided. The compositions are intended for administration as a nebulized aerosol. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.Type: ApplicationFiled: August 2, 2002Publication date: February 5, 2004Applicant: Dey, L.P.Inventors: Partha S. Banerjee, Ramana R. Malladi, Imtiaz A. Chaudry
-
Patent number: 6667344Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.Type: GrantFiled: June 22, 2001Date of Patent: December 23, 2003Assignee: Dey, L.P.Inventors: Partha S. Banerjee, Stephen Pham, Samuel O. Akapo, Imtiaz A. Chaudry
-
Patent number: 6632842Abstract: The present invention relates to a dual bronchodilator inhalation solution, system, kit and method for relieving bronchospasm in patients suffering from chronic obstructive pulmonary disease (COPD). In one alternative embodiment, the solution of the present invention is a prepackaged, sterile, premixed, premeasured single unit dose of albuterol and ipratropium bromide for patients suffering from COPD. The present solution may be free of antimicrobial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 2.50 mg albuterol and about 0.50 mg ipratropium bromide.Type: GrantFiled: June 3, 2002Date of Patent: October 14, 2003Assignee: Dey, L.P.Inventors: Imtiaz Chaudry, Partha Banerjee
-
Publication number: 20030140920Abstract: The present invention relates to an albuterol inhalation solution, system, kit and method for relieving bronchospasm in children suffering from asthma. In one alternative embodiment, the solution of the present invention is a sterile, premixed, premeasured single unit dose of albuterol for asthmatic patients 2 to 12 years of age. The present solution may be free of anti-microbial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 0.63 mg or about 1.25 mg albuterol.Type: ApplicationFiled: October 18, 2002Publication date: July 31, 2003Applicant: Dey L.P.Inventors: Imtiaz Chaudry, Partha Banerjee
-
Publication number: 20030055026Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof, and a steroidal anti-inflammatory agent. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchocon-strictive disorders using the compositions provided herein are also provided.Type: ApplicationFiled: June 22, 2001Publication date: March 20, 2003Applicant: Dey L.P.Inventors: Partha S. Banerjee, Imtiaz A. Chaudry
-
Publication number: 20020151597Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.Type: ApplicationFiled: June 22, 2001Publication date: October 17, 2002Applicant: Dey L.P.Inventors: Partha S. Banerjee, Stephen Pham, Samuel O. Akapo, Imtiaz A. Chaudry